Cardiovascular Discovery Group, Kolling Institute of Medical Research, University of Sydney, St Leonards 2065, Australia.
Department of Cardiology, Royal North Shore Hospital, St Leonards 2065, Australia.
Cells. 2022 Feb 8;11(3):588. doi: 10.3390/cells11030588.
Cardiac biomarkers have become pivotal to the clinical practice of cardiology, but there remains much to discover that could benefit cardiology patients. We review the discovery of key protein biomarkers in the fields of acute coronary syndrome, heart failure, and atherosclerosis, giving an overview of the populations they were studied in and the statistics that were used to validate them. We review statistical approaches that are currently in use to assess new biomarkers and overview a framework for biomarker discovery and evaluation that could be incorporated into clinical trials to evaluate cardiovascular outcomes in the future.
心脏生物标志物已成为心脏病学临床实践的关键,但仍有许多有待发现的内容可以使心脏病患者受益。我们回顾了在急性冠状动脉综合征、心力衰竭和动脉粥样硬化领域中关键蛋白生物标志物的发现,概述了研究这些标志物的人群以及用于验证这些标志物的统计学方法。我们还回顾了目前用于评估新生物标志物的统计方法,并概述了一个可以纳入临床试验的生物标志物发现和评估框架,以便未来评估心血管结局。